Announcements Trials
Browse Landscape Eligibility

Clinical Trials

2 trials
RecentStart dateEnrollment
TEMPO × Clear all

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Motor Activity 2Anxiety Disorders 2Neoplasms 1

Interventions

Cyclophosphamide 2681Cisplatin 2665Carboplatin 2462Radiotherapy 2370Paclitaxel 2264Gemcitabine 2128pembrolizumab 1993Docetaxel 1883Bevacizumab 1821Fluorouracil 1548Capecitabine 1532Oxaliplatin 1440Dexamethasone 1330Nivolumab 1300Doxorubicin 1260Rituximab 1249Magnetic Resonance Spectroscopy 1150Etoposide 1126Irinotecan 1038Leucovorin 1020Drug Therapy 999Cytarabine 964Pemetrexed 891fludarabine 889Specimen Handling 822Vincristine 793Lenalidomide 791Cetuximab 785Prednisone 785Trastuzumab 785

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT06363266 2025-05-06

A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers

St. Mary's Research Center, Canada

Phase NA Recruiting
376 enrolled
Genitourinary

Anxiety Disorders, Motor Activity, Prostatic Neoplasms

NCT04304196 2021-09-21

TEMPO

St. Mary's Research Center, Canada

Phase NA Completed
82 enrolled
Genitourinary

Anxiety Disorders, Motor Activity, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡